NEW YORK, Oct. 13, 2021 (PRNewswire) – Jeffrey Young has joined the executive team as Chief Technology Officer today. The company also hired Sarah Hostst, director of digital products, as a key leader in the digital team.

Lyfebulb hires first members of the Digital Product Engineering Team.

“We are delighted to welcome Jeff and Sarah,” said Karin Heinberger, MD, PhD, CEO of Lyfebulb. With our TransplantLyfe This year, we are moving our clinical, patient-centered approach to digital healthcare. This ad is one of the many steps that many communities have taken to create a collection of digital platforms where patient communities can meet, be encouraged and educate themselves.

Jeffrey brings in-depth technical and management experience to the Lyfebulb team. Jeffrey spent the past 20 years working with primary companies and helping to open more than 50 companies and products. A.D. He founded Arabella LLC, a digital production agency in 2011, acquired by Roman Health Ventures in 2018. He has worked with some new healthcare companies as a specialist in building production and engineering teams for primary companies. Like Oscar Health, Ro and Calibrate. Jeff BS received a degree in Computer Science from Carnegie Melon University.

Sarah spends most of her time building, developing, launching and replicating technology products and startups. Prior to joining Lyfebulb, she was the founder, CEO and CEO of two technology startups at WorkStrive and Place Tempo in Health, Safety, Fitness and Productivity. Prior to that, Sarah worked with both business and engineering teams (leading software QA) in Boston for consumers and SaaS Enterprise technology startups, which in turn worked for healthcare companies. Sarah Magna Kum Laud graduated with a degree in advertising and entrepreneurship from Apalchian State University.

“It is refreshing to find a company that combines a deep understanding of patient travel with the need to innovate and digitalize that clinical knowledge into devices that help patients understand each other. Young concluded.

About LyfebulbLyfebulb is a breakthrough that bridges the gap between patient communities and the healthcare industry by working directly with patients and caregivers to create awareness and reduce the burden of chronic disease. Lyfebulb works in 11 disease states and counts. watch out,, Facebook, Twitter, Instagram, LinkedIn, And Andreas Hehenberger LinkedIn.

ContactKarin Hehenberger, MD, PhDCEO and Founder, LyfebulbPhone ፡ +1 917-575-0210 Email Free

Cision View original content to download multimedia

Source Lyfebulb